High efficacy and safety of VTD as an induction protocol in patients with newly diagnosed multiple myeloma eligible for high dose therapy and autologous stem cell transplantation: A report of the Polish Myeloma Study Group.

Published in:

Oncology Letters, 2019, v. 18, n. 6, p. 5811, doi. 10.3892/ol.2019.10929

By:

• Hus, Iwona;
• Mańko, Joanna;
• Jawniak, Dariusz;
• Jurczyszyn, Artur;
• Charliński, Grzegorz;
• Poniewierska-Jasak, Katarzyna;
• Usnarska-Zubkiewicz, Lidia;
• Sawicki, Mateusz;
• Druzd-Sitek, Agnieszka;
• Świderska, Alina;
• Kopińska, Anna;
• Grząśko, Norbert;
• Raźny, Małgorzata;
• Wędłowska, Aleksandra;
• Perzyński, Aleksander;
• Gałązka, Aleksandra;
• Dytfeld, Dominik;
• Kubicki, Tadeusz;
• Rodzaj, Marek;
• Waszczuk-Gajda, Anna

Publication type:

Article